Pacific Biosciences of California, Inc.: net_income
| Value | {"amount": -314200000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | Pacific Biosciences of California, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:22:27.402567+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c2626535-a928-4def-9144-73fe15e13e50
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001299130-26-000064Retrieved: 2026-08-19T12:22:27.402567+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001299130/net-income/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c2626535-a928-4def-9144-73fe15e13e50
History
- supersedes {"amount": -314248000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001299130-23-000032)